Deutsch (DE-CH-AT)English (United Kingdom)Russian (CIS)
  • Increase font size
  • Default font size
  • Decrease font size
Please wait while JT SlideShow is loading images...
Nanostart AGNanostart AGNanostart AG

Nanostart AG News

Press releases

Nanostart invests in Singapore medical technology company BioMers

Frankfurt / Singapore – December 18, 2009 – Nanostart AG has taken a significant ownership position in BioMers Pte Ltd, a Singapore-based medical technology company with a branch office in the U.S. The company is developing innovative new solutions for various biomedical applications with its technology.

Read more...

Nanostart majority-owned MagForce Nanotechnologies AG names Dr. Peter Heinrich as new CEO

Berlin / Frankfurt – December 10, 2009 – MagForce Nanotechnologies AG (Entry Standard segment of the Frankfurt Stock Exchange, ticker MF6), the Berlin-based medical technology company majority owned by Nanostart AG, has announced the appointment of Dr. Peter Heinrich as its new chief executive officer effective January 1, 2010.

Read more...

Nanostart further increases ownership of ItN Nanovation

Frankfurt – December 08, 2009 – Nanostart AG, the Frankfurt-based nanotechnology investment company, is increasing its shareholding in ItN Nanovation AG (ISIN DE000A0JL461 /WKN A0JL46), a cleantech innovator based in Saarbrücken, Germany, from 26.5 percent to almost 27.2 percent.

Read more...

Nanostart-owned MagForce Nanotechnologies AG: Application submitted for EU regulatory approval of Nano-Cancer® therapy

Frankfurt / Berlin –December 1, 2009 – MagForce Nanotechnologies AG, the Berlin-based medical nanotechnology company, majority-owned by Nanostart AG, has submitted its application for the European regulatory approval of its Nano-Cancer® therapy.

Read more...

Nanostart to feature successful completion of MagForce clinical trials at investor presentation in New York City

Frankfurt – November 4, 2009 – Marco Beckmann, CEO of Nanostart AG, the global nanotechnology investment company based in Frankfurt, will be presenting the company and its portfolio holdings to an audience of approx. 80 selected investors and analysts on November 5 in New York City’s Manhattan Club.

Read more...

Nanostart majority-owned MagForce announces successful completion of final clinical trials for Nano-Cancer® therapy

Frankfurt / Berlin – November 3, 2009 – MagForce Nanotechnologies AG, the Berlin-based medical technology company majority owned by Nanostart AG, today announced the successful completion of final trials demonstrating the efficacy of its Nano-Cancer® therapy in patients with recurrent glioblastoma, a frequent form of brain tumor which is highly malignant. The actual study results significantly exceeded the study objective.

Read more...

Nanostart increases investment in promising portfolio company Curiox

Frankfurt am Main / Singapore – 28. October 2009 – Nanostart has increased its stake in Curiox Biosystems Pte Ltd, Singapore, to almost 19% by a follow-up investment through its Nanostart Singapore Early Stage Venture Fund I.

Read more...

Nanocoating by Nanostart holding ItN Nanovation is flying to the Mercury

Saarbrücken / Frankfurt – October 01, 2009 – Nanostart holding ItN Nanovation AG (ISIN DE000A0JL461) with its high expertise and successful work in the field of nanoscale coatings has been selected to develop important thermal coatings for the BepiColombo Mercury probe of the European space agency ESA and JAXA, the Japanese Space Agency.

Read more...

Page 1 of 6

  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  Next 
  •  End 
  • »
You are here: 2009